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Abstract
Since 1999 the World Health Organization issues annually an additional influenza vaccine composition recommendation.
This initiative aimed to extend to the Southern Hemisphere (SH) the benefits—previously enjoyed only by the Northern
Hemisphere (NH)—of a vaccine recommendation issued as close as possible to the moment just before the onset of the
influenza epidemic season. A short time between the issue of the recommendation and vaccine delivery is needed to
maximize the chances of correct matching between putative circulating strains and one of the three strains present in the
vaccine composition. Here we compare the effectiveness of the SH influenza vaccination adopted in Brazil with hypothetical
alternative scenarios defined by different timings of vaccine delivery and/or composition. Scores were based on the
temporal overlap between vaccine-induced protection and circulating strains. Viral data were obtained between 1999 and
2007 from constant surveillance and strain characterization in two Brazilian cities: Bele ´m, located at the Equatorial region,
and Sa ˜o Paulo, at the limit between the tropical and subtropical regions. Our results show that, among currently feasible
options, the best strategy for Brazil would be to adopt the NH composition and timing, as in such case protection would
increase from 30% to 65% (p,.01) if past data can be used as a prediction of the future. The influenza season starts in Brazil
(and in the equator virtually ends) well before the SH winter, making the current delivery of the SH vaccination in April too
late to be effective. Since Brazil encompasses a large area of the Southern Hemisphere, our results point to the possibility of
these conclusions being similarly valid for other tropical regions.
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Introduction
Influenza is one of the most important infectious diseases of
humans, and one of the main reasons is that immunity to influenza
virus is not life-lasting (as in most of the diseases induced by
viruses). This ephemeral period of protection to influenza is due to
the fact that the two glycoproteins that protrude from influenza
viruses membrane (and therefore the only ones our immune
system have access to recognize and ‘‘memorize’’) have a capacity
to mutate frequently, generating varieties different enough to
prevent the identification from previous infections, while main-
taining their important roles as (among others) binding and
releasing sites to the host cells. The natural selection of these viable
and rapid antigenic changes in those surface proteins results in the
constant necessity of formulating new vaccines for each new
influenza season every year. Influenza vaccine effectiveness hence
varies each season and depends on how well the vaccine strains
match the circulating strains, as well as whether serum antibody
response has peaked in the target population before the epidemic
arrives [1,2,3]. Predicting which strains have the highest
probability of circulating in the next season six months ahead
(time to produce and distribute the vaccine [2,4]) based on the
study of globally prevailing strains in previous seasons is the
challenging task of the World Health Organization (WHO) Global
Influenza Program [2,4,5].
Since the first annual meeting of the WHO Global Influenza
Program in 1973 recommendations have been issued in
February, so that vaccines could be made available to the
population six months later, before the northern hemisphere
winter. Countries in the southern hemisphere only had this
recommendation to follow from the WHO, meaning vaccine
composition would be determined almost one year in advance of
the epidemic season in this region (driving some countries of the
Southern Hemisphere -Australia, New Zealand and South Africa-
to produce customized vaccines based on their own surveillance
[6]).
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already when the first influenza vaccination campaign took place,
in the winter of 1998 in the state of Sao Paulo (the campaign was
restricted to that state). In that occasion, Brazilian surveillance
identified intense epidemic activity of an influenza A/H3N2 strain
not included in the northern hemisphere vaccine composition (A/
Sydney/5/1997 (H3N2) was circulating whereas the vaccine
contained A/Wuhan/359/95 (H3N2)) [6]. In September of the
same year WHO issued its first recommendation specifically
designed for the southern hemisphere in anticipation of the
following winter (June–September 1999), which was then
immediately adopted in Brazil in its first nationwide campaign,
aimed at providing coverage for the population at highest risk of
severe disease outcomes: seniors (.65 years old in the year 1999
and .60 years old since 2000), people suffering from chronic
conditions or HIV, as well as health care professionals [6,7].
In the first three years following its implementation a good
match between circulating virus strains and strains included in the
recommended composition of the southern hemisphere vaccine
was identified (data collected by the Brazilian surveillance project
showed 91%,100% and 10% matching between the vaccine
composition and the identified strains in 1999,2000, and 2001
respectively [6], although—as we are going to see in this study—
timing of circulation relative to vaccine delivery is a critical issue
that affects these matching rates). More recently, however, health
authorities in Brazil have been discussing the possibility of
changing the influenza vaccination calendar for the northern
areas of the country due to the perception of the early onset of
influenza epidemics in this region [8,9,10]—something our results
will show to be also relevant to a much wider range of latitudinal
zones than has been anticipated until now.
Brazil encompasses a large variety of climates, ranging from
equatorial in the North (5.2uN) to subtropical in the South
(33.7uS). Previous studies have shown that both the subtropical
[6,11,12] and equatorial regions of Brazil experience seasonal
influenza epidemics, but there is a latitudinal gradient in the
timing of the peak of local epidemics, which occurs nearly
3 months earlier (March–April) in the North when compared to
southernmost regions [8,9,10]. Thus, the viral surveillance data
collected regularly over the last decades are of utmost importance
to evaluate the effectiveness of vaccination campaigns adopted
both in equatorial and tropical regions.
The tropics generally have mild or warm climates and are
positioned between the temperate regions where more severe and
defined cold seasons alternate each year. Influenza activity in the
tropics is more temporally diffuse than the peaks shown at higher
latitudes [13], and epidemics display a diversity of seasonal
patterns driven by factors not yet clearly understood. For all these
reasons, the tropics have less clearly defined seasonality and
patterns of trans-hemispheric viral circulation potentially chal-
lenging vaccination strategy [7,13,14].
In this study, and based on data from constant surveillance and
strain characterization in two Brazilian cities located at the
Equator and at the limit between the tropical and subtropical
regions (figure 1), we quantify the effectiveness of the influenza
vaccination strategy adopted in Brazil and compare it with
alternative ones, where vaccination schedule is changed and/or
vaccine composition relies on that recommended for the northern
hemisphere. ‘‘Effectiveness’’ therefore is operationally defined for
the purposes of this study as the proportion of matches between
strains present in the vaccine each year and those circulating after
the vaccination in the immediately following epidemiological
season. By measuring ‘effectiveness’ in this way this study thus
accepts the same assumptions about the immunological benefits
for the targeted population of a higher match between vaccine
composition and circulating strains as those that support the
issuing of vaccine recommendations every year for both
hemispheres by the WHO.
Materials and Methods
Localities studied
The study is based on surveillance of circulating strains
identified at two Brazilian cities situated in two places of the
tropics of special interest: one is at the core of the tropical region,
at a few kilometers from the equatorial line, and the other at its
southern boundary – in fact crossed by the tropic of Capricorn line
(figure 1).
The city of Bele ´m is located in the Amazonian region at 1.4uSo f
latitude, and lies in the mouth of the Amazon River. It has an
equatorial climate, hot and humid throughout the year, with
especially high precipitations during the first half of the year.
Bele ´m has approximately 2 million inhabitants and it is the capital
of the state of Para ´ (see climatic profile at figure 1). In its
immediate surroundings, in the district of Ananindeua, is located
the Evandro Chagas Institute (IEC), a research center for
epidemiology and public health from where the Bele ´m data used
in this study is originated.
The metropolitan area of Sa ˜o Paulo, crossed by the Tropic of
Capricorn, is located at 23.4uS (figure 1) and about 50 kilometers
from the coast and 760 meters above sea level. It has a subtropical
climate with moderate winters and precipitations concentrated in
the warm summer months (see climatic profile at figure 1). With
approximately 20 million inhabitants, it is the largest city of the
southern hemisphere. Adolfo Lutz Institute (IAL), located in Sa ˜o
Paulo, is a National Laboratory on Public Health and a
Macroregional Reference Laboratory, and provided us with the
material and data from this region.
Characterization of influenza strains and in Bele ´m and
Sa ˜o Paulo
Weekly influenza surveillance is conducted routinely by the two
above mentioned Institutes, which also participate at the WHO
Global Influenza Surveillance Network (GISN). The sampling
effort of this data collection is constant all year round and is part of
the influenza national surveillance network of the Brazilian
Ministry of Health. It is important to highlight that, although
centered in influenza surveillance, this systematic collection of
samples also contribute to the investigation of other etiologic
agents involved in acute respiratory diseases (which is another
reason why the sampling effort is held constant during the entire
year). IEC actively sends a technician to collect samples in a local
health care center unit near Bele ´m every week. IAL, on the other
hand, receives the samples from several sentinel health centers
where local physicians have been trained on the detection of
relevant cases and on sampling and delivering methods. The
samples from Sa ˜o Paulo used in this study are mainly from health
centers located in the city of Sa ˜o Paulo, with some samples from
localities within a perimeter of 300 kilometers around the city.
Influenza specimens are identified from nasopharyngeal aspi-
rates or swabs taken from outpatients with influenza-like illness.
The samples are being tested for Influenza A and B by RT-PCR
or Indirect Immunofluorescence, and positive samples are selected
for virus isolation and characterized genetically and antigenically
following the standard protocol of the Centers for Disease Control
and Prevention (CDC, WHO Collaborating Center for Surveil-
lance, Epidemiology and Control of Influenza). Influenza virus
isolation (in eggs or MDCK cells) is a laboratory procedure that
Influenza Vaccination
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approximately 10%). Factors associated with genetic variability
of the circulating strains contribute for this occurrence. This
explains why so few influenza characterizations are usually
available for each country per year (as can be verified at WHO’s
Flunet website http://gamapserver.who.int/GlobalAtlas/home.
asp).
For the two laboratories involved in this study the annual
average of virus isolations and characterizations during 1999–2007
(the period encompassed by this study) were, respectively, 2.3 and
2.5 per year at the IEC and IAL Institutes. There was an almost
complete matching between the virus strains isolated and those
present in the composition of vaccine (produced from extensive
surveillance all around the globe) within the same years (Table 1;
Figure S1.1), indicating that such sampling effort was indeed
representative of circulating virus variants.
Seasonal patterns
In order to contribute to the description of the seasonal patterns
of influenza in Bele ´m and Sa ˜o Paulo, we also conducted basic
exploratory statistical analyses using the number of influenza
isolates aggregated by month and data from 1991 to 2007 (with
the exception of 1992 and 1993, when surveillance was
interrupted at IEC). We analyzed the frequencies of monthly
isolates in both localities using circular (azimuthal) statistics to
identify the midpoint of the epidemic season [15]. The
concentration of isolates in this time cycle is expressed with the
Kappa index, which indicates how the data vectors cluster around
the mean (with zero representing evenly dispersed data, hence no
seasonal peak) [15].
For comparison purposes, we plotted the average monthly
mortality rate from pneumonia and influenza from 1996 to 2005
in each city and surrounding ‘‘microregion’’ as previously
described [8], based on data provided by the Brazilian Institute
of Geography and Statistics (www.ibge.gov.br/english).
Analyses of vaccination effectiveness according to
different scenarios, 1999–2007
To evaluate and compare the alternative vaccination strategies,
we analyzed the time series representing the circulation of different
influenza virus strains by subtype and city, relative to the time
period when the influenza vaccine would effectively protect the
target population. We estimated the proportion of seasons with a
correct match of strains circulating and present in the vaccine
composition, as defined by the temporal overlap between vaccine-
induced protection and circulating strains. Data for the southern
and northern hemisphere recommendation can be found on the
WHO website [16].
Every year a cohort of people who had never been vaccinated
in previous years is vaccinated. Therefore we wanted to
determine the effectiveness of the campaign at each single year,
minimizing the residual effects of the population already
protected for a specific strain at the time of vaccination (i.e.
current season) owing to the effect of vaccination in the previous
Figure 1. Map of South America, showing the location of Bele ´m and Sa ˜o Paulo, and key monthly climatic indicators in these cities
(continuous line represents mean temperatures, and bars represent precipitations). Climatic data are averaged for the period from 1961
to 1990—as made available by the Brazilian Institute of Meteorology [26]
doi:10.1371/journal.pone.0005095.g001
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protection of 9 months following vaccination, to reduce the
possibility of considering as a positive match the temporal overlap
between (1) a circulating strain in the current epidemiologic
season and (2) the immunization to that strain in the immediately
previous epidemiologic season. Since 9 months of protection was
assumed, the year of 1999 was included because absence of
southern hemisphere vaccination in 1998 does not affect the
comparison of strategies in 1999 (only if we had detected in
January of 1999 a strain already present in the vaccine, but that
was not the case). The analyses were conducted independently for
each city (so that we could account for the epidemiologic
specificities of each locality) followed by an overall analysis
considering both cities together.
We first performed our analyses according to an historical
vaccine scenario (here referred to as ‘‘scenario 1’’), i.e. considering
those vaccination campaigns that were actually implemented in
Brazil, as following to southern hemisphere composition recom-
mendations and schedules. The vaccination campaign is generally
conducted during the second half of April and the first week of
May and, although the timing of vaccination campaigns varied
slightly according to year, we considered that protective vaccine
response was achieved by early May.
Secondly, we estimated vaccine match for alternative hypothet-
ical strategies, relying on the Northern Hemisphere vaccine
recommendations and/or earlier timings of vaccination (similarly
assuming that protective vaccine response was achieved in the
month following that of the vaccination campaign). Those
hypothetical scenarios are specified below:
(scenario 2) Northern hemisphere composition delivered
at current southern schedule. This scenario assumes the use
of the same composition as that issued for the northern
hemisphere and delivery at the same time as the currently
adopted schedule for the southern hemisphere (April). Technically,
this strategy would be the simplest one, as producers of vaccines
for Brazil would be able to know the composition of the vaccine
well before (approximately 12 months in advance) the time of
delivery.
(scenario 3) Southern hemisphere composition delivered
three months earlier than the current schedule. This
scenario assumes that, from the time the Southern
recommendation is issued in September, vaccine manufacturers
would have only three months to produce and distribute the
vaccine. This is not feasible under current methods of vaccine
production, but shortening the time of the production of vaccines
has been a priority [17]. We therefore analyze this scenario to
evaluate this possibility in case it is made available in a short future.
(scenario 4) Northern hemisphere composition as
administered in the North hemisphere. Under this
scenario vaccines would be delivered using the same
composition as that issued for the Northern Hemisphere as well
as the same delivery time (November). This scenario therefore
checks the matching of circulating strains against vaccine
composition as if the Southern Hemisphere recommendation
had never existed, with Brazil adopting the same vaccine
composition and timing as the countries of the Northern
hemisphere (i.e. delivery is assumed thus to occur just before the
Southern Hemisphere summer).
Table 1. WHO influenza vaccine recommendations for the Southern and Northern Hemisphere, 1999–2007: antigenic
characterization of the strains recommended for inclusion in the trivalent vaccine, by hemisphere, influenza season and subtype
[16].
Northern Hemisphere
Season A/H3N2 A/H1N1 B
1998–99 A/Sydney/5/97 A/Beijing/262/95 B/Beijing/184/93
1999–00 A/Sydney/5/97 A/Beijing/262/95 B/Beijing/184/93
2000–01 A/Panama/2007/99 A/New Caledonia/20/99 B/Beijing/184/93
2001–02 A/Panama/2007/99 A/New Caledonia/20/99 B/Sichuan/379/99
2002–03 A/Panama/2007/99 A/New Caledonia/20/99 B/Hong Kong/330/2001 *
2003–04 A/Panama/2007/99 A/New Caledonia/20/99 B/Hong Kong/330/2001
2004–05 A/Fujian/411/2002 A/New Caledonia/20/99 B/Shanghai/361/2002 *
2005–06 A/California/7/2004 * A/New Caledonia/20/99 B/Shanghai/361/2002
2006–07 A/Wisconsin/67/2005 * A/New Caledonia/20/99 B/Malaysia/2506/2004
Southern Hemisphere
Season A/H3N2 A/H1N1 B
1999 A/Sydney/5/97 A/Beijing/262/95 B/Beijing/184/93
2000 A/Panama/2007/99 * A/New Caledonia/20/99 * B/Beijing/184/93
2001 A/Panama/2007/99 A/New Caledonia/20/99 B/Sichuan/379/99 *
2002 A/Panama/2007/99 A/New Caledonia/20/99 B/Sichuan/379/99
2003 A/Panama/2007/99 A/New Caledonia/20/99 B/Hong Kong/330/2001
2004 A/Fujian/411/2002 * A/New Caledonia/20/99 B/Hong Kong/330/2001
2005 A/Wellington/1/2004 * A/New Caledonia/20/99 B/Shanghai/361/2002
2006 A/California/7/2004 A/New Caledonia/20/99 B/Malaysia/2506/2004 *
2007 A/Wisconsin/67/2005 A/New Caledonia/20/99 B/Malaysia/2506/2004
Asterisks (*) indicate a change in vaccine composition from the previous recommendations.
doi:10.1371/journal.pone.0005095.t001
Influenza Vaccination
PLoS ONE | www.plosone.org 4 April 2009 | Volume 4 | Issue 4 | e5095The results obtained from these different hypothetical scenarios
are summarized in a table. The results of the historical scenario
are then compared with those from the hypothetical alternatives
with two-tailed chi-square (x
2
1) statistics (contingency tables used
historical versus hypothetical scenario; number of matches versus
number of non-matches).
Cross-protection between strains and data aggregation
We considered influenza viral strains based on their hemaglu-
tinin characteristics, as this surface protein is the key component
of natural and vaccine-induced immunity. We are aware that
cross-protection can make vaccinated individuals immunocom-
petent to different strains, what would interfere in this
quantification of ‘‘effectiveness’’ [3]. Nevertheless we believe this
should not affect the validity of our findings because: 1) all
scenarios –historic and hypothetical - are equally exposed to this
putative effect, hence not representing a bias of the results in any
specific direction; 2) here we adopt the same assumptions as those
that the WHO adopts to suggest different vaccine compositions
each year, therefore considering the complete match a superior
strategy than to rely in a putative cross-reaction of the strains
considered [3].
Still, and based on the guidelines provided by the WHO [16],
we assumed full cross protection for the following strains of
influenza B: Hong-Kong/330/2001, Brisbane/32/2002 and
Hong-Kong/1434/2002 in the Victoria lineage, and Beijing/
184/93 and Yamanashi/166/98 in the Yamagata lineage, and
therefore aggregated them accordingly.
Some strains were isolated in more than one month during the
s a m es e a s o na n di nt h es a m ec i t y .I ns u c hc a s e s ,w ec o n s i d e r e d
only the month of the first isolation to avoid replication of the
same information, and because the effectiveness of the
vaccination scenarios is measured according to their capacity
to protect the population before the strains begin to circulate in
that season.
Results
Influenza seasonal patterns in Bele ´m and Sa ˜o Paulo
During the 1991–2007 period of routine influenza laboratory
surveillance, 29 isolates were selected for isolation and character-
ization in Bele ´m and 38 isolates in Sa ˜o Paulo. Sampling efforts
were constant throughout the year, but most influenza viruses
were isolated during January and May in Bele ´m, with more
activity occurring in March and April (Figure 2A). Similarly,
influenza viruses were isolated as early as January in Sa ˜o Paulo,
with higher activity occurring in April and June (figure 2b). The
average annual timing of influenza isolation, as obtained using
azimuthal statistics, was slightly earlier in Bele ´m (end of March,
fig 2A) than in Sa ˜o Paulo (end of April, Figure 2B), yet, this
difference in timing dispersion was not statistically significant
(p=0.17, i.e. we could not reject the hypothesis that the vector
means were the same in Sa ˜o Paulo and Bele ´m [18]). The temporal
dispersion around the mean, as measured by the Kappa index, was
also similar – in fact slightly lower in Sa ˜o Paulo (1.38) as compared
to Bele ´m (1.45).
For comparison with viral activity data, we also explored
seasonal patterns in mortality from pneumonia and influenza.
Kappa in this case was lower for Bele ´m (0.11) than Sa ˜o Paulo
(0.21), suggesting a stronger degree of seasonality in mortality in
the latter city , although the dispersion in both cases is quite low,
almost uniform, so seasonal effects probably are small in both
places. Bele ´m again have shown more intense activity earlier than
Sa ˜o Paulo, but this time with a difference of almost three (2.8)
months (Figures 2C and 2D), mainly due to the late activity
detected in Sa ˜o Paulo in June. Statistical analyses on mortality
numbers (without converting them to population ratios) indeed
rejected the null hypothesis that the vector mean of mortality were
the same in Bele ´m and Sa ˜o Paulo (p,0.001).
Overall, virus surveillance data for this period confirms the
seasonal trends evidenced in the analysis of mortality data by
Figure 2. Comparison of influenza seasonal patterns in Bele ´m and Sa ˜o Paulo using laboratory versus vital statistics data. Top panels
(A,B) are based on monthly laboratory-confirmed influenza surveillance between 1991 and 2007 Bottom panels (C,D) illustrate monthly mortality rates
per 100,000 from pneumonia and influenza (P&I) between 1996 and 2005. Standard deviation are represented as vertical bars. Triangles in each panel
represent the mid-point of the influenza season, based on azimuthal (circular) statistics.
doi:10.1371/journal.pone.0005095.g002
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Bele ´m (although statistical analyses of the viral data could not
distinguish the mean annual timing of virus data in Bele ´m and Sa ˜o
Paulo with statistical significance).
Changes in vaccine recommendations between the
Northern and Southern Hemisphere
Three antigens are included in the composition of the vaccine
every year (A/H3N2, A/H1N1, and B), thus totaling 27
antigens for the 9-year study period from 1999 to 2007.
Table 1 lists vaccine recommendations by hemisphere and
season during this period. Six changes were first introduced in
the Southern Hemisphere recommendations, so that a total of
21 strains (78%) present in the recommended composition for
the Southern hemisphere were also present in the recommen-
dations for the Northern hemisphere 6 months earlier. Of the
six changes first introduced in the Southern Hemisphere
recommendation, 3 were for influenza A/H3N2, 2 for influenza
A/H1N1 and 1 for influenza B. During the same study period, 4
changes to vaccine composition were first introduced in the
Northern Hemisphere recommendations (2 for influenza A/
H3N2, 2 for influenza B).
Analyses of influenza vaccination effectiveness according
to different scenarios, 1999–2007
The strains of influenza viruses isolated in Bele ´m and Sa ˜o Paulo
between 1999 and 2007 are shown in figure 3 by subtype and city,
and in Figure S1 (where the process of determining matches
between vaccine composition and subsequent circulating strains is
explained in detail).
The results showing the effectiveness of vaccination for the
different scenarios are shown in Table 2. Cells indicate the
number and proportion (in parenthesis) of seasons where strains
isolated in Sa ˜o Paulo and Bele ´m were correctly matched (in terms
of composition and timing of vaccine delivery) with each
vaccination strategy. The total number of strains identified in
each location is indicated in the headers (without repetition in the
same season, influenza subtype, year and place).
Had it been administered in January rather than April (scenario 3
– Southern hemisphere composition delivered three months earlier than the current
Figure 3. Matching success of vaccine strategies against strains of influenza viruses isolated monthly from 1999 to 2007 in Bele ´m
and Sa ˜o Paulo. The different categories of influenza strains considered in the study period are indicated on the vertical axis, sorted by influenza
subtype (influenza A) and lineage (influenza B) and identification date. Time is measured on the horizontal axis. Strains isolated each month are
represented by green diamonds for Bele ´m, and green circles for Sa ˜o Paulo (blank symbols represent subsequent isolations of the same strain in the
same season, and therefore were not considered for the analysis). Stars represent the first month of the period of vaccination-induced protection,
while the following dotted lines represent the remaining months of protection. Red lines correspond to historical vaccination strategy adopted by the
Brazilian authorities (i.e. relying on the southern hemisphere vaccine recommendations and schedule). Blue lines represent a hypothetical scenario
whereby the northern hemisphere vaccination recommendations and schedule are used in both cities. The rate of successful matches between
vaccines and circulating strains is quantified by the overlap between vaccine data (blue or red lines, depending on the scenario analyzed) and actual
virus isolations (green circles and diamonds) through this period.
doi:10.1371/journal.pone.0005095.g003
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southern hemisphere vaccine would have more than doubled (from
30% to 70%) the proportion of correct vaccine matches with
observed influenza epidemics (Table 2; chi-square, p,.01).
Surprisingly, the hypothetical scenario relying on the composition
and schedule defined by the northern hemisphere recommendations
(scenario 4) would have also doubled (from 30% to 65%) the
proportionofcorrectmatches(Figure2;Table2;chi-square,p,.01).
These results were also statistically significant for each city
independently. An unexpected finding is that these results are
consistent both for the equatorial city of Bele ´m and for the
southern city of Sa ˜o Paulo, which is located on the very transition
to the sub-tropical region (figure 1). This finding was consistent for
all 3 influenza (sub)types, although weaker for the H1N1 group
due to its lower rate of antigenic change during this period.
Discussion
Under the challenge given by the constant appearance of new
influenza strains, delaying for as long as possible the final decision
about the composition of the vaccine is without doubt extremely
useful, as it increases the chances of successful immunization
[2,3,4,5,6]. Nevertheless, our analysis points to additional
complexities that are present in the tropical region, where the
concept of ‘hemispheres’ that is so useful for higher latitudes
cannot be unequivocally applied.
In this line we have found that, paradoxically, the southern
hemisphere vaccination campaign does not stand as the optimal
choice for Brazil, the biggest country of the Southern Hemisphere
and the second most populated (after Indonesia). In fact, the
southern hemisphere recommendations are delivered too late for
the whole range of tropical latitudes of Brazil, as the vaccine is
offered when the epidemiologic season is already at an advanced
stage.
We have described elsewhere [8,9,10] that Brazilian regions
near the equator had earlier influenza activity than Southern
regions. In those lower latitudes precipitation – not low
temperatures – has been frequently pointed out as the driving
factor [7,8,9,10,19] facilitating the circulation of influenza viruses -
in fact, precipitation is more intense in the first semester of the year
in Bele ´m. Accordingly, here we found that the pattern of virus
isolation in Bele ´m (Figure 2A) – concentrated in the first half of the
year - is consistent with the seasonal patterns of mortality due to
pneumonia and influenza in that city (Figure 2C). In Sa ˜o Paulo
there was also a major presence of isolates of influenza in the
beginning of winter (June), a result expected for a subtropical city
with colder winters. But, unexpectedly, we have also shown in Sao
Paulo - similarly to the observation for Bele ´m - high levels of
influenza virus activity along the first half of the year (Figure 2B).
This early activity is not associated with increased pneumonia and
influenza mortality (Figure 2A). Indeed, circulation of influenza
viruses without significant increases in influenza morbidity or
mortality has already been described [20]. It is beyond the scope of
this study to seek an understanding of the causes underlying this
discrepancy, but we can speculate that intense viral activity in the
northern hemisphere winter could drive the early activity in Sa ˜o
Paulo (a megalopolis with intense movement of passengers from
and to the Northern Hemisphere), while occurrence of severe
clinical outcomes following infection may be limited to winter
climatic conditions in later months of the year. This could also
explain why some studies point to the positive impact of the
implementation of influenza vaccination in the South of Brazil
[21,22], while failing to detect such effects in the Northeast [23] –
see [7] for a critical review.
In any case, of pivotal importance for the evaluation of the
vaccination strategies is the fact that, due to this early viral activity
in Sa ˜o Paulo, there was not a significant difference in the overall
timing of viral activity (as measured by the vector means of the
distribution of the isolates) between both cities. And since both
cities essentially shared the same antigenic strains of influenza
virus, along with the similar timing of epidemic onset, the effects of
the different vaccination strategies were equivalent for both places:
one city in the very core of the tropical zone, and another in its
Southern geographic limit.
Despite limited resources and a wide range of health related
demands, influenza vaccine is delivered free of charge nationwide
in Brazil since 1999 to the population at highest risk of severe
disease outcomes [6,7]. Until it is not possible to implement the
southern hemisphere recommendation three months earlier than it
is currently delivered (the best strategy as pointed by our results),
the adoption of the composition and schedule recommended for
the northern hemisphere in the northern region of Brazil should
be seriously considered. The adoption of such a solution should
not present major logistical challenges, as Brazil is attaining self-
sufficiency in vaccine production (currently produced by the
‘‘Butantan Research Institute’’, located in Sa ˜o Paulo).
Tropical regions are increasingly being acknowledged as being
of crucial importance for the study of circulation of influenza. In
fact, recent studies of the genetic and antigenic characteristics of
influenza A virus suggest that the tropics may contain foci for the
emergence of new strains [24,25]. In addition, the tropics also
encompass most of the countries with fewer resources for research
and health surveillance. Together, these issues hinder the
implementation of effective influenza vaccination strategies in
the area. The data for this study came from two distant Brazilian
cities, representing a large range of climatic, latitudinal, and
demographic characteristics. The convergence of results suggests
that the relevance of our findings is not restricted to the localities
we studied, but could prove pertinent to many other tropical
Table 2. Success of vaccination campaigns in Brazil for the historical and simulated alternative strategies (1999–2007).
Vaccination Scenarios Bele ´m (n=17) Sa ˜o Paulo (n=20) Overall (n=37)
Historical (1) Southern formulation, delivered following southern schedule (April) 5 (29%) 6 (30%) 11 (30%)
Hypothetical (2) Northern formulation, delivered following southern schedule (April) 3 (18%) 7 (35%) 10 (27%)
(3) Southern formulation, delivered earlier than southern schedule (January) 12* (71%) 14* (70%) 26** (70%)
(4) Northern formulation, delivered following northern schedule (October) 11* (65%) 13* (65%) 24** (65%)
*p,0.05 and
**p,0.01: statistically significant difference in the number of positive matches (virus in the vaccine and circulating virus) between the historical and the hypothetical
vaccination scenario examined.
doi:10.1371/journal.pone.0005095.t002
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regions of Africa, Asia, and Oceania are warranted.
Supporting Information
Figure S1 This figure illustrates the algorithm used to estimate
the proportion of match for different vaccination strategies in
Belem and Sao Paulo, Brazil, using data on influenza activity
during 1999 to 2007 in these cities and assuming that vaccination
protection lasts for 9 months. The different categories of influenza
strains considered in the study period are indicated on the vertical
axis, sorted by influenza subtype (influenza A) or lineage (influenza
B) and identification date. Time is measured on the horizontal
axis. Strains isolated each month are represented by green
diamonds for Belem, and green circles for Sao Paulo (white
symbols mean repeated isolations in that season, therefore not
considered). Stars represent the first month of the period of
vaccination-induced protection, while the following dotted lines
represent the remaining months. Red lines correspond to historical
vaccination strategy adopted by the Brazilian authorities (i.e.
relying on the southern hemisphere vaccine recommendations and
schedule). Blue lines represent a hypothetical scenario whereby the
northern hemisphere vaccination recommendations and schedule
are used in both cities. Successful matches between vaccine and
circulating strains were encircled by hand and counted (partial and
total ‘‘T=’’ counts also shown) originally in these supplementary
figures. Data shown in Figures S1.1 and S1.4 are summarized in
figure 3 of the main text, and estimates of the proportion of
matched seasons for the 4 strategies considered here are given in
Table 2.
Found at: doi:10.1371/journal.pone.0005095.s001 (0.40 MB
DOC)
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